Axcess Global Sciences, LLC v. Hard Eight Nutrition, LLC
2:25-cv-00942
Overview
Parties
Defendant
Hard Eight Nutrition, LLC Operating Company
Represented By
0 Attorneys ListedPlaintiff
Court & Judges
Court
District Court, D. Nevada (nvd)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 10,245,243 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 18,891,741 | European Counterpart (EP) | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | EP 3,727,360 A4 | European Counterpart (EP) | View Official Patent → |
| π PCT International (WIPO) | WO 2019125693 A1 | PCT World Application | View Official Patent → |
| π―π΅ Japan | JP 2020533584 A | Japan Counterpart | View Official Patent → |
| π―π΅ Japan | JP 7300449 B2 | Japan Counterpart | View Official Patent → |
| π¨π³ China | CN 2018800825 | China Counterpart | View Official Patent → |
| π¨π³ China | CN 111655244 A | China Counterpart | View Official Patent → |
| π¨π¦ Canada | CA 3086517 A | Canada Counterpart | View Official Patent → |
| πΊπΈ United States | US 10,596,128 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,596,130 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,185,518 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,973,786 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,202,769 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,786,499 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10245243
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
|
Filed: 2018-03-27
Issued: 2019-04-02
|
Active (11.5 yrs remaining)
+45d PTA
Expires: 2038-05-11
|
|
|
US10588876
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
Filed: 2018-12-18
Issued: 2020-03-17
|
Active (12.1 yrs remaining)
Expires: 2038-12-18
|
|
|
US10596128
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
|
Filed: 2018-12-18
Issued: 2020-03-24
|
Active (12.1 yrs remaining)
Expires: 2038-12-18
|
|
|
US10596129
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
Filed: 2019-02-11
Issued: 2020-03-24
|
Active (12.2 yrs remaining)
Expires: 2039-02-11
|
|
|
US10596130
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
|
Filed: 2019-02-11
Issued: 2020-03-24
|
Active (12.2 yrs remaining)
Expires: 2039-02-11
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
2
Granted
3
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings